Who's Who in Gerontology: Companies

Found 55 companies.
  • A
  • Aelan Cell Technologies

    Biotech developing stem-cell therapies by removing age-related constraints on stem cell vitality, as well as epigenetic aging biomarkers under licence from the Buck Institute.

    More Details ›
  • AgeX Therapeutics

    AgeX is developing stem-cell and cellular reprogramming therapies to regenerate tissues.

    More Details ›
  • Alkahest

    Alkahest is a clinical stage biopharmaceutical company developing therapies for neurodegenerative and age-related diseases by targeting specific chronokines, the proteins that increase or decrease with age.

    More Details ›
  • Alterity Therapeutics

    They are primarily focused on developing treatments for neurodegenerative diseases.

    More Details ›
  • Antoxis

    Antoxis is developing therapeutic antioxidants for treatment of age-related diseases like Alzheimer disease.

    More Details ›
  • Apollo Health Ventures

    They are an investment company that aims to develop interventions with the potential to prevent or reverse age-related diseases and extend healthy human lifespan.

    More Details ›
  • B
  • BIOAGE Labs

    A VC-backed biotech company aimed at finding drugs that extend healthspan using machine learning and biomarkers.

    More Details ›
  • BioMarker Pharmaceuticals

    Their goal is to develop pharmaceuticals and other therapies for the treatment and prevention of age-related disease. Their research is largely based on caloric restriction and DNA microarrays.

    More Details ›
  • C
  • Calico

    The mission of Google-backed Calico is to harness advanced technologies to increase our understanding of the biology that controls lifespan. They then aim to use that knowledge to devise interventions that enable people to lead longer and healthier lives.

    More Details ›
  • Celularity

    Clinical-stage cell therapeutics company delivering allogeneic cellular therapies, engineered from the postpartum human placenta, in cancer immunotherapy and functional regeneration.

    More Details ›
  • Centagen

    They are developing multi-path therapeutics for age-related disorders via activating adult stem cells.

    More Details ›
  • Centaura

    Founded by longevity evangelist Vitaly Ponomarev, Centaura aims to identify the primary drivers of degeneration in each organ using systems biology, machine learning, and artificial intelligence, in order to generate novel predictors to guide clinical intervention.

    More Details ›
  • Chronos Therapeutics

    Company screening novel and repositioned drugs for the treatment of age-related conditions, particularly neurodegenerative diseases and osteoporosis.

    More Details ›
  • Cleara Biotech

    Targeting cellular senescence to extend human healthspan at old age and to counteract therapy resistance in late stage cancer. Based on the work of Peter de Keizer.

    More Details ›
  • CohBar

    Research and development of mitochondria based therapeutics for aging-related diseases and metabolic dysfunction, including non-alcoholic steatohepatitis, obesity, Type 2 diabetes, cancer, cardiovascular disease and CNS disorders.

    More Details ›
  • E
  • Elevian

    Elevian is developing a number of therapeutics that regulate GDF11 and other circulating factors, in order to restore the natural regenerative capacity of the body, addressing a root cause of age-associated diseases.

    More Details ›
  • Elysium Health

    They offer an epigenetic age measurement as well as supplements to boost NAD+.

    More Details ›
  • Everon Biosciences

    Everon is developing small molecules and immunotherapeutics to block or slow down age-related waste products or facilitate their removal, as well as an aging diagnostic platform.

    More Details ›
  • F
  • Five Alarm Bio

    They are developing a small molecule approach to boost the body defence to aging, based on a new understanding of how the chemical damage associated with age accumulates in cells.

    More Details ›
  • G
  • GeneCare Research Institute Co

    They are primarily focused on cancer and inflammation, but have some interests in aging.

    More Details ›
  • Genescient

    Company employing evolutionary genomics and genetics to develop therapeutics that target diseases of aging.

    More Details ›
  • GenSight Biologics

    Clinical-stage gene-therapy company discovering, developing and commercializing novel therapies for patients with severe retinal neurodegenerative diseases.

    More Details ›
  • Gero

    Gero is a data-driven longevity company focused on the development of new treatments to combat the aging process and extend healthy human lifespans, primarily around the topic of stability and stress resistance of gene regulatory networks.

    More Details ›
  • Geron

    The company's technology is largely centered around the telomeres and telomerase. They have interests in stem cells and cloning, but their main focus is on cancer.

    More Details ›
  • H
  • Human Longevity, Inc. (HLI)

    By focusing on genomics, informatics, and stem cell therapies, HLI aims to tackle aging and aging-related diseases.

    More Details ›
  • I
  • Ichor Therapeutics

    Ichor is a group of companies developing drugs to target various classes of molecular damage driving aging, including Lysoclear, Fox Bio, Antoxerene, Auctus Biologics.

    More Details ›
  • Insilico Medicine

    They employ machine-learning techniques for drug discovery and repurposing for cancer and age-related diseases.

    More Details ›
  • J
  • Juvena Therapeutics

    Juvena plans to discover novel protein-based therapeutics that promote tissue regeneration in the elderly and treat various age-related diseases, combining proteomics and with machine-learning analysis of microscopy.

    More Details ›
  • Juvenescence

    They create and partner with new companies with longevity-related therapeutics, aiming to develop therapies that will enable people worldwide to live longer, healthier lives.

    More Details ›
  • Juvenon

    Juvenon develop and market nutritional supplements for healthy aging that aim to prevent the decay of mitochondria.

    More Details ›
  • L
  • L-Nutra

    Develops and produces fasting-mimicking diet products to enhance healthspan based on aging research by Valter Longo.

    More Details ›
  • Legendary Pharmaceuticals

    They aim to develop drugs and therapies to prevent and treat age-related diseases. Their strategy is based on repairing and reversing progressive damage to mitochondria and lysosomes.

    More Details ›
  • Libella Gene Therapeutics

    Libella aims to complete a human trial using AAV/hTERT to treat or significantly improve Alzheimer disease using telomerase gene therapy.

    More Details ›
  • Life Biosciences

    Founded by David Sinclair, they aim to develop medicines for aging in its entirety by setting up several daughter companies focused on the hallmarks of aging.

    More Details ›
  • Life Length

    Life Length provides services in telomere and telomerase measurement and diagnostics.

    More Details ›
  • Longeveron

    Developing a cell-based therapy for aging frailty, Alzheimer disease, and metabolic syndrome.

    More Details ›
  • Longevity Biotech

    Longevity Biotech is working to develop modulators of natural defense mechanisms in order to develop new therapeutic compounds.

    More Details ›
  • Longevity Vision Fund

    Founded by longevity investor and visionary Sergey Young, they aim to make longevity accessible and affordable by funding life extension breakthroughs.

    More Details ›
  • M
  • Mitotech

    Development of pharmaceutical products based on mitochondria targeted antioxidants for treatment of age-related disorders, including dry eye.

    More Details ›
  • N
  • Navitor Pharmaceuticals

    Clinical-stage biotech focused on selective targeting of mTORC1 activators and inhibitors for different age- and non-age-related indications.

    More Details ›
  • O
  • Oisin Biotechnologies

    Oisin is developing a novel class of therapeutics, Proteo-Lipid Vehicles containing DNA, to kill senescent and cancer cells.

    More Details ›
  • P
  • Ponce de Leon Health

    Their first product, Rejuvant, is a dietary supplement, coupled with a non-invasive DNA methylation test to estimate biological aging.

    More Details ›
  • Proteostasis Therapeutics

    Proteostasis Therapeutics develops drugs that control the body's protein homeostasis which could lead to therapies against genetic and degenerative disorders that include several age-related diseases.

    More Details ›
  • R
  • Rejuvenate Bio

    Developing treatments for animal aging and age-related diseases. Currently focusing on treating dog mitral valve disease with gene therapy.

    More Details ›
  • Rejuvenate Biomed

    The company plans to repurpose safe and well tolerated prescription drugs that could impact the aging process.

    More Details ›
  • resTORbio

    They develop a pipeline targeting mTOR with RTB101, alone or in combination with sirolimus or rapalogs, for neurodegenerative diseases or diseases associated with TORC1 hyperactivation.

    More Details ›
  • Retrotope

    Retrotope focuses on the development of ways of controlling metabolic processes associated with oxidative stress, in particular neurodegenerative diseases.

    More Details ›
  • S
  • Sibelius

    They have a focus on screening natural compounds and nutraceuticals for their therapeutic benefits in treating age-related conditions. This is the sister company of Chronos Therapeutics.

    More Details ›
  • Sierra Sciences

    Sierra Sciences is a biotechnology company whose long-term goal is to develop drugs and therapies that will cure and prevent human diseases associated with aging. Presently, they focus mainly on telomeres and telomerase.

    More Details ›
  • Signum Biosciences

    Company developing therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's disease by studying protein networks.

    More Details ›
  • Siwa Therapeutics

    A pre-clinical stage company with a humanized monoclonal antibody, SIWA 318H, that selectively targets both senescent cells and cancer cells.

    More Details ›
  • Spring Discovery

    A machine learning platform combined with cell- and tissue-based assays to accelerate experimentation for discovering anti-aging therapies.

    More Details ›
  • T
  • Turn Bio

    They focus on cellular reprogramming to address most of the hallmarks of aging and rejuvenate tissues. Initial candidate applications are osteoarthritis, skin damage, and sarcopenia.

    More Details ›
  • U
  • Underdog Pharmaceuticals

    The company is developing a novel class of cyclodextrins to target toxic forms of cholesterol in atherosclerosis.

    More Details ›
  • Unity Biotechnolology

    Unity is developing a number of therapies to eliminate senescent cells in order to halt, slow or reverse age-associated disease.

    More Details ›
Found 55 companies.